Skip to main content

Table 7 Comparison between efficacy profiling and toxicity profiling of Olmesartan medoxomil

From: In silico assessment of chronic toxicity of a combination drug namely ‘Olmesartan medoxomil and Hydrochlorothiazide’, marketed in Bangladesh

Drug-1

Drug-2

Olmesartan medoxomil

Hydrochlorothiazide

Protein

Group

Vina binding affinity

Protein

Group

Free energy

Tyrosine protein kinase JAK2 receptor

Efficacy

− 8.5

Carbonic amhydrases

Efficacy

N/A

Caspase-8

Toxicity

− 7.1

Glutamate receptor ionotropic, AMPA 1, AMPA 2

Efficacy

N/A

COX-2

Toxicity

− 8.3